Picture of China NT Pharma logo

1011 China NT Pharma Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for China NT Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-583-200-149-54.3
Depreciation
Amortisation
Non-Cash Items59966.664.782.7
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1.67135-93-13.2
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities47.826.2-13536.2
Capital Expenditures-87.2-23.8-0.646-4.49
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1206192589.02
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2075962584.53
Financing Cash Flow Items-99.2-66.1-43.3-19.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities101-624-125-46.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-59.6-20.41.61-2.45
0